<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24632862</article-id>
      <article-id pub-id-type="pmc">4108782</article-id>
      <article-id pub-id-type="publisher-id">14-0057</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.14-0057</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Pathology</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Malignant Epithelioid Schwannoma of the Oral Cavity in a Cat</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>BOONSRIROJ</surname>
            <given-names>Hassadin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KIMITSUKI</surname>
            <given-names>Kazunori</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>AKAGI</surname>
            <given-names>Tetsuya</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>PARK</surname>
            <given-names>Chun-Ho</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Department of Veterinary Pathology, School of Veterinary
Medicine, Kitasato University, 23&#x2013;35&#x2013;1, Higashi, Towada, Aomori 034&#x2013;8628, Japan</aff>
        <aff id="aff2"><label>2)</label>Akagi Animal Hospital, 1900, Takao, Niimi, Okayama 718&#x2013;0003,
Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Park, C.-H., Associate Professor,
Department of Veterinary Pathology, School of Veterinary Medicine, Kitasato University,
23&#x2013;35&#x2013;1 Higashi, Towada, Aomori 034&#x2013;8628, Japan. e-mail: <email xlink:href="baku@vmas.kitasato-u.ac.jp">baku@vmas.kitasato-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2014</year>
      </pub-date>
      <volume>76</volume>
      <issue>6</issue>
      <fpage>927</fpage>
      <lpage>930</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2014 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>ABSTRACT</title>
        <p>A malignant epithelioid schwannoma of the oral cavity was diagnosed in an
8-year-old domestic short-hair cat. The mass was located in the gingiva of the upper left
premolar to molar region and showed multinodular growth patterns. The mass comprised
epithelioid cells arranged in densely packed sheets. Tumor cells had large, round to oval
nuclei with prominent nucleoli and an abundant eosinophilic cytoplasm.
Immunohistochemically, most of the tumor cells were positive for S-100 protein, glial
fibrillary acidic protein and vimentin, but all lacked melanoma-associated antigen and
muscle and neuroendocrine markers. Stains for type IV collagen showed linear
immunoreactivity around single cells and groups of cells. Ultrastructurally, tumor cells
were separated by a well-defined basement membrane, and interdigitating cell processes
were observed. To our knowledge, this is the first report of feline malignant epithelioid
schwannoma.</p>
      </abstract>
      <kwd-group>
        <kwd>feline</kwd>
        <kwd>malignant epithelioid schwannoma</kwd>
        <kwd>oral cavity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Schwannomas (peripheral nerve sheath tumors) are common tumors of the peripheral nervous
system of domestic animals and have been reported in dogs [<xref rid="r3" ref-type="bibr">3</xref>], cats [<xref rid="r14" ref-type="bibr">14</xref>], horses [<xref rid="r13" ref-type="bibr">13</xref>] and cows [<xref rid="r15" ref-type="bibr">15</xref>]. By contrast,
malignant epithelioid schwannoma is an unusual variant of peripheral nerve sheath tumor that
closely resembles carcinoma or melanoma because the tumor comprises exclusively Schwann cells
with a polygonal epithelioid appearance [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r8" ref-type="bibr">8</xref>]. In humans, this tumor was reported to originate from
peripheral nerves including the sciatic, facial, digital and antebrachial cutaneous nerves
[<xref rid="r17" ref-type="bibr">17</xref>]. In domestic animals, only two canine cases in
the trigeminal nerve [<xref rid="r12" ref-type="bibr">12</xref>] and subcutaneous tissue
[<xref rid="r5" ref-type="bibr">5</xref>] have been described. In the present study, we
describe the first case of feline malignant epithelioid schwannoma in the oral cavity.</p>
    <p>An 8-year-old, intact female domestic short-hair cat was presented to the local private
animal hospital with a 6-week history of swelling of the left maxillofacial area. A large
gingival mass was observed at the left upper premolar to molar teeth. There was no previous
medical or surgical history. The gingival mass was surgically removed and fixed in 10%
buffered formalin. The mass was 3.0 &#xD7; 1.0 &#xD7; 0.6 cm in size and solid and firm with an
irregular surface. At the cut surface, the mass was greyish-white and exhibited multinodular
growth patterns (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>At the cut surface, the mass appears solid, firm and greyish-white. Bar=1 cm.</p></caption><graphic xlink:href="jvms-76-927-g001"/></fig>). At the first admission to hospital, metastasis was not observed in the thoracic and
abdominal cavity by radiographic and computed tomography examinations.</p>
    <p>The mass was embedded in paraffin wax. Serial sections were cut at 3 <italic>&#xB5;</italic>m and
stained with hematoxylin and eosin (HE), periodic acid&#x2013;Schiff (PAS), Gomori&#x2019;s reticulin silver
impregnation and for immunohistochemistry. The following primary antibodies were used: S-100
protein (Nichirei Biosciences, Tokyo, Japan), vimentin (Nichirei), glial fibrillary acidic
protein antibody (GFAP, Nichirei), type IV collagen (Dako Japan, Kyoto, Japan), cytokeratin
(CK) AE1/ AE3 (Nichirei), &#x3B1;-smooth muscle actin (SMA, Dako Japan,), desmin (Dako Japan),
calretinin (Zymed Laboratory, South San Francisco, CA, U.S.A.), PNL2 (Dako Japan) and Melan-A
(Dako Japan) (<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Primary antibodies used for the immunohistochemical examination and results</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Antibody<sup>a)</sup></th><th align="center" rowspan="1" colspan="1">Clone</th><th align="center" rowspan="1" colspan="1">Source</th><th align="center" rowspan="1" colspan="1">Dilution</th><th align="center" rowspan="1" colspan="1">Antigen retrieval<sup>b)</sup></th><th align="center" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Vimentin</td><td align="left" rowspan="1" colspan="1">V9</td><td align="center" rowspan="1" colspan="1">Nichirei</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">MW, 170W, 10 min</td><td align="left" rowspan="1" colspan="1">Positive, diffuse</td></tr><tr><td align="left" rowspan="1" colspan="1">S-100</td><td align="left" rowspan="1" colspan="1">4C4.9</td><td align="center" rowspan="1" colspan="1">Nichirei</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">No treatment</td><td align="left" rowspan="1" colspan="1">Positive, diffuse</td></tr><tr><td align="left" rowspan="1" colspan="1">GFAP</td><td align="left" rowspan="1" colspan="1">GA5</td><td align="center" rowspan="1" colspan="1">Nichirei</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">No treatment</td><td align="left" rowspan="1" colspan="1">Positive, diffuse</td></tr><tr><td align="left" rowspan="1" colspan="1">Type IV collagen</td><td align="left" rowspan="1" colspan="1">CIV22</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">1: 100</td><td align="left" rowspan="1" colspan="1">Pro-K, 37&#xB0;C, 10 min</td><td align="left" rowspan="1" colspan="1">Positive, diffuse</td></tr><tr><td align="left" rowspan="1" colspan="1">Cytokeratin</td><td align="left" rowspan="1" colspan="1">AE1/ AE3</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">1: 50</td><td align="left" rowspan="1" colspan="1">Pro-K, 37&#xB0;C, 10 min</td><td align="left" rowspan="1" colspan="1">Positive, scattered</td></tr><tr><td align="left" rowspan="1" colspan="1">SMA</td><td align="left" rowspan="1" colspan="1">1A4</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">1: 1000</td><td align="left" rowspan="1" colspan="1">No treatment</td><td align="left" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Desmin</td><td align="left" rowspan="1" colspan="1">D33</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">No treatment</td><td align="left" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Calretinin</td><td align="left" rowspan="1" colspan="1">DC8</td><td align="center" rowspan="1" colspan="1">Zymed</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">AC, 121&#xB0;C, 10 min</td><td align="left" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">PNL2</td><td align="left" rowspan="1" colspan="1">PNL2</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">AC, 121&#xB0;C, 10 min</td><td align="left" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Melan-A</td><td align="left" rowspan="1" colspan="1">A103</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">1: 300</td><td align="left" rowspan="1" colspan="1">AC, 121&#xB0;C, 10 min</td><td align="left" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Ki-67</td><td align="left" rowspan="1" colspan="1">MIB-1</td><td align="center" rowspan="1" colspan="1">Dako</td><td align="center" rowspan="1" colspan="1">Prediluted</td><td align="left" rowspan="1" colspan="1">MW, 750W, 10 min</td><td align="left" rowspan="1" colspan="1">Positive, 35%</td></tr></tbody></table><table-wrap-foot><p>a) GFAP: glial fibrillary acidic protein, SMA: &#x3B1;-smooth muscle actin. b) AC: autoclave,
MW: microwave, Pro-K: Proteinase K.</p></table-wrap-foot></table-wrap>). The localization of the antigens was visualized with 3,3&#x2032;-diaminobenzidine
solution (Dako Japan). Finally, the sections were counterstained with hematoxylin. To
investigate the proliferation rate of the tumor cell population, Ki-67 MIB-1 (Ki-67, Dako
Japan) positive nucleoli were scored by counting at least 1,000 cells in representative &#xD7; 400
high-power fields. For electron microscopic examination, the formalin-fixed sample was cut
into 1 mm<sup>3</sup> blocks, post-fixed in 1% buffered osmium tetroxide and embedded in epoxy
resin. Sections (about 70 <italic>n</italic>m thick) were stained with uranyl acetate and lead
citrate and examined using a transmission electron microscope (H-7650, Hitachi, Tokyo,
Japan).</p>
    <p>Microscopically, at low-power view, the mass was not encapsulated and had grown invasively
into the vertical margin in multinodular patterns (<xref ref-type="fig" rid="fig_002">Fig.
2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>At low-power view, the mass displays multinodular growth patterns. HE. Bar=500
<italic>&#xB5;</italic>m</p></caption><graphic xlink:href="jvms-76-927-g002"/></fig>). The major components of the tumor were epithelioid cells arranged in densely packed
sheets (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>The major components of the tumor are epithelioid cells arranged in densely packed
sheets. HE. Bar=50 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-76-927-g003"/></fig>). Tumor cells had large, centrally located, round to oval nuclei, and the nucleoli were
usually single and prominent. The amount of eosinophilic cytoplasm in the tumor cells was
variable, and the cytoplasmic borders were distinct. Occasionally, atypical cells with
intranuclear eosinophilic pseudoinclusions were observed (<xref ref-type="fig" rid="fig_004">Fig. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>Tumor cells shows nuclear atypia, and nucleoli are prominent. Occasionally,
intranuclear eosinophilic inclusions (arrows) are observed in the atypical cells. HE.
Bar=25 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-76-927-g004"/></fig>). The mitotic index was 5 in 10 &#xD7; 400 high-power fields. Hemorrhage and focal necrosis
were observed. PAS staining revealed glycogen granules in the cytoplasm of the tumor cells,
and silver staining showed a delicate network of reticulin fibers around nests and along
sheets of cells (<xref ref-type="fig" rid="fig_005">Fig. 5</xref><fig orientation="portrait" fig-type="figure" id="fig_005" position="float"><label>Fig. 5.</label><caption><p>Individual tumor cells are surrounded by thin reticular fibers. Reticulin silver
impregnation. Bar=25 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-76-927-g005"/></fig>). As shown in the other histological findings, a few individual mast cells were
scattered throughout the tumor, and aggregations of small numbers of lymphocytes and
neutrophils were observed.</p>
    <p>Immunohistochemically, most of the tumor cells were strongly and diffusely positive for S-100
protein (<xref ref-type="fig" rid="fig_006">Fig. 6A</xref><fig orientation="portrait" fig-type="figure" id="fig_006" position="float"><label>Fig. 6.</label><caption><p>(A&#x2013;D). Most tumor cells are diffusely positive for S-100 (A), GFAP (B), vimentin (C)
and type IV collagen (D). Immunostaining for type IV collagen outlines a latticework of
basement membrane material around individual cells (D). Immunohistochemistry. Bar=25
<italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-76-927-g006"/></fig>), GFAP (<xref ref-type="fig" rid="fig_006">Fig. 6B</xref>) and vimentin (<xref ref-type="fig" rid="fig_006">Fig. 6C</xref>), and CK AE1/AE3 positive cells were scattered.
S-100 protein staining was found in the cytoplasm and nuclei of the tumor cells. By contrast,
none of the tumor cells expressed melanoma-associated antigens (Melan-A, PNL2), muscle markers
(desmin, SMA) or neuroendocrine markers (calretinin). Immunostaining for type IV collagen
outlined a latticework of basement membrane material around individual cells (<xref ref-type="fig" rid="fig_006">Fig. 6D</xref>) and groups of cells. The Ki-67 proliferation
index was 35% (<xref rid="tbl_001" ref-type="table">Table 1</xref>).</p>
    <p>Ultrastructurally, the polygonal tumor cells were separated by variable amounts of collagen
fibers, and some cells showed long cytoplasmic processes (<xref ref-type="fig" rid="fig_007">Fig. 7</xref><fig orientation="portrait" fig-type="figure" id="fig_007" position="float"><label>Fig. 7.</label><caption><p>Tumor cells are surrounded by variable amounts of stromal connective tissues, and some
cells shows long cytoplasmic processes. Electron microscopy. Bar=10
<italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-76-927-g007"/></fig>). Interdigitating cell processes were also observed. Cytoplasmic margins were well
defined, and a basal lamina enveloped each cell. Nucleoli were large and irregular, and
cytoplasmic organelles, such as mitochondria, rough endoplasmic reticulum, free ribosomes,
glycogen granules and Golgi apparatus, were sparse. Occasionally, intracytoplasmic bundles of
microfilaments and lysosome-like granules were seen (<xref ref-type="fig" rid="fig_008">Fig.
8</xref><fig orientation="portrait" fig-type="figure" id="fig_008" position="float"><label>Fig. 8.</label><caption><p>Tumor cell is surrounded by variable amounts of collagen fibers (cf) and basal lamina
(arrows). Intracytoplasmic bundles of microfilaments (mf) and lysosome-like granules are
observed in the interdigitating cell processes. N=nucleus, Electron microscopy. Bar=1
<italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-76-927-g008"/></fig>), but melanin granules, axons, myelin or microtubules were not observed.</p>
    <p>Generally, schwannoma is an encapsulated nerve sheath tumor comprising two components: a
highly ordered cellular component (Antoni A area) and a loose myxoid component (Antoni B area)
[<xref rid="r18" ref-type="bibr">18</xref>]. Verocay bodies are rows of nuclear arrangements
that are separated by anuclear zones of eosinophilic fibrillar material and are common in
Antoni A areas; these are also seen in feline tumors [<xref rid="r14" ref-type="bibr">14</xref>]. Like a conventional schwannoma, epithelioid variants of schwannoma develop as a
circumscribed and encapsulated mass, but Antoni A and B patterns are not observed in the
epithelioid population as this case.</p>
    <p>Differentiating between a benign and malignant epithelioid schwannoma is sometimes difficult,
because both types have a similar morphological appearance. But, usually, benign epithelioid
schwannoma shows superficial location, small size, low mitotic activity, insignificant
cellular atypia, lack of necrosis and a high degree of schwannian differentiation [<xref rid="r7" ref-type="bibr">7</xref>]. The malignant epithelioid form is unusual, and the most
characteristic appearance is densely packed multinodules of epithelioid cells arranged in a
sheet-like pattern with large, round, pleomorphic nuclei with prominent nucleoli and the high
mitotic index [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r12" ref-type="bibr">12</xref>].</p>
    <p>The labeling indices of tumor proliferation markers, such as Ki-67 and p53, differ between
benign and malignant schwannomas. In humans, the mean Ki-67 and p53 labeling indices for
benign schwannoma were reported as&lt;5% and&lt;1%, whereas those for malignant epithelioid
schwannoma were 5&#x2013;65% and 5&#x2013;100%, respectively [<xref rid="r6" ref-type="bibr">6</xref>]. In
the present case, the Ki-67 proliferation index was 35%. The ranges of the Ki-67 and p53
labeling indices in these reports are wide, and the expression of these markers has not been
investigated in feline epithelioid schwannoma. However, it was considered that the present
results of the immunohistochemistry of Ki-67 suggested malignant properties.</p>
    <p>In the present case, the tumor cells sometimes had intranuclear eosinophilic inclusions.
These intranuclear inclusions are found in schwannomas and in other tumors including
meningiomas [<xref rid="r20" ref-type="bibr">20</xref>], paragangliomas [<xref rid="r4" ref-type="bibr">4</xref>], pheochromocytomas [<xref rid="r4" ref-type="bibr">4</xref>] and
pituitary tumors [<xref rid="r19" ref-type="bibr">19</xref>]. Intranuclear inclusions in these
tumors are formed by cytoplasmic invagination and comprise cytoplasmic organelles, such as
rough endoplasmic reticulum, the Golgi apparatus and secretory granules [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r19" ref-type="bibr">19</xref>]. To our knowledge,
intranuclear inclusions have not been reported in malignant epithelioid schwannoma in cats.
Therefore, further data collection is needed to understand better the relationship between the
intranuclear inclusions and malignancy of epithelioid schwannoma in cats.</p>
    <p>The most common malignant tumor of the oral cavity in dogs is melanoma [<xref rid="r11" ref-type="bibr">11</xref>]. By contrast, oral melanoma is uncommon, and oral amelanotic melanoma
is extremely rare in cats [<xref rid="r10" ref-type="bibr">10</xref>]. Immunohistochemical
analysis shows that both types of oral melanoma strongly express Melan-A and S-100 protein. In
the present case, most of the tumor cells stained positively for S-100 protein, GFAP, vimentin
and type IV collagen, but all cells were negative for melanoma-associated antigens. In
addition, the most characteristic findings in the melanoma, such as melanin pigments,
lamellipodia, filopodia and evidence of ruffling and endocytosis, are not observed by electron
microscopy [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r16" ref-type="bibr">16</xref>]. Therefore, the possibility of a tumor originating from melanocytes was excluded
from the differential diagnosis.</p>
    <p>Distant metastasis and spread of malignant epithelioid schwannomas to regional lymph nodes
have been reported in humans, but the rate of metastasis is generally low [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>]. In the present
case, no evidence of additional tumor growth, invasion or metastasis was found during the
14-month follow-up, and we concluded that this tumor had a low malignancy compared with oral
malignant melanoma and that the prognosis was good after complete surgical excision.</p>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Alvira</surname><given-names>M. M.</given-names></name><name><surname>Mandybur</surname><given-names>T. K.</given-names></name><name><surname>Menefee</surname><given-names>M. G.</given-names></name></person-group><year>1976</year>
<article-title>Light microscopic and ultrastructural
observations of a metastasizing malignant epithelioid schwannoma</article-title>.
<source><italic>Cancer</italic></source><volume>38</volume>:
<fpage>1977</fpage>&#x2013;<lpage>1982</lpage>. doi: <pub-id pub-id-type="doi">10.1002/1097-0142(197611)38:5&lt;1977::AID-CNCR2820380519&gt;3.0.CO;2-I</pub-id><pub-id pub-id-type="pmid">991111</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Cheville</surname><given-names>N. F.</given-names></name></person-group><year>1994</year> Secretory granules. pp. 246&#x2013;251. <italic>In</italic>:
Ultrastructural Pathology, 1st ed. (Cheville, N. F. ed), Iowa State University Press,
Ames.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Chijiwa</surname><given-names>K.</given-names></name><name><surname>Uchida</surname><given-names>K.</given-names></name><name><surname>Tateyama</surname><given-names>S.</given-names></name></person-group><year>2004</year>
<article-title>Immunohistochemical evaluation of canine
peripheral nerve sheath tumors and other soft tissue sarcomas</article-title>.
<source><italic>Vet. Pathol.</italic></source><volume>41</volume>:
<fpage>307</fpage>&#x2013;<lpage>318</lpage>. doi: <pub-id pub-id-type="doi">10.1354/vp.41-4-307</pub-id><pub-id pub-id-type="pmid">15232130</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>DeLellis</surname><given-names>R. A.</given-names></name><name><surname>Suchow</surname><given-names>E.</given-names></name><name><surname>Wolfe</surname><given-names>H. J.</given-names></name></person-group><year>1980</year>
<article-title>Ultrastructure of nuclear &#x201C;inclusions&#x201D; in
pheochromocytoma and paraganglioma</article-title>. <source><italic>Hum.
Pathol.</italic></source><volume>11</volume>: <fpage>205</fpage>&#x2013;<lpage>207</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0046-8177(80)80147-X</pub-id><pub-id pub-id-type="pmid">6249715</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Garc&#xED;a</surname><given-names>P.</given-names></name><name><surname>S&#xE1;nchez</surname><given-names>B.</given-names></name><name><surname>S&#xE1;nchez</surname><given-names>M. A.</given-names></name><name><surname>Gonz&#xE1;lez</surname><given-names>M.</given-names></name><name><surname>Roll&#xE1;n</surname><given-names>E.</given-names></name><name><surname>Flores</surname><given-names>J. M.</given-names></name></person-group><year>2004</year>
<article-title>Epithelioid malignant peripheral nerve
sheath tumor in a dog</article-title>. <source><italic>J. Comp.
Pathol.</italic></source><volume>131</volume>: <fpage>87</fpage>&#x2013;<lpage>91</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.jcpa.2003.12.012</pub-id><pub-id pub-id-type="pmid">15144803</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kindblom</surname><given-names>L. G.</given-names></name><name><surname>Ahld&#xE9;n</surname><given-names>M.</given-names></name><name><surname>Meis-Kindblom</surname><given-names>J. M.</given-names></name><name><surname>Stenman</surname><given-names>G.</given-names></name></person-group><year>1995</year>
<article-title>Immunohistochemical and molecular
analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and
malignant peripheral nerve sheath tumors</article-title>. <source><italic>Virchows
Arch.</italic></source><volume>427</volume>: <fpage>19</fpage>&#x2013;<lpage>26</lpage>. doi:
<pub-id pub-id-type="doi">10.1007/BF00203733</pub-id><pub-id pub-id-type="pmid">7551341</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kindblom</surname><given-names>L. G.</given-names></name><name><surname>Meis-Kindblom</surname><given-names>J. M.</given-names></name><name><surname>Havel</surname><given-names>G.</given-names></name><name><surname>Busch</surname><given-names>C.</given-names></name></person-group><year>1998</year>
<article-title>Benign epithelioid
schwannoma</article-title>. <source><italic>Am. J. Surg.
Pathol.</italic></source><volume>22</volume>: <fpage>762</fpage>&#x2013;<lpage>770</lpage>.
doi: <pub-id pub-id-type="doi">10.1097/00000478-199806000-00015</pub-id><pub-id pub-id-type="pmid">9630185</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Laskin</surname><given-names>W. B.</given-names></name><name><surname>Weiss</surname><given-names>S. W.</given-names></name><name><surname>Bratthauer</surname><given-names>G. L.</given-names></name></person-group><year>1991</year>
<article-title>Epithelioid variant of malignant
peripheral nerve sheath tumor (malignant epithelioid schwannoma)</article-title>.
<source><italic>Am. J. Surg. Pathol.</italic></source><volume>15</volume>:
<fpage>1136</fpage>&#x2013;<lpage>1145</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00000478-199112000-00004</pub-id><pub-id pub-id-type="pmid">1746681</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Lodding</surname><given-names>P.</given-names></name><name><surname>Kindblom</surname><given-names>L. G.</given-names></name><name><surname>Angervall</surname><given-names>L.</given-names></name></person-group><year>1986</year>
<article-title>Epithelioid malignant schwannoma: A study
of 14 cases</article-title>. <source><italic>Virchows. Arch. A Pathol. Anat.
Histopathol.</italic></source><volume>409</volume>:
<fpage>433</fpage>&#x2013;<lpage>451</lpage>. doi: <pub-id pub-id-type="doi">10.1007/BF00705415</pub-id><pub-id pub-id-type="pmid">3090772</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Patnaik</surname><given-names>A. K.</given-names></name><name><surname>Mooney</surname><given-names>S.</given-names></name></person-group><year>1988</year>
<article-title>Feline melanoma: a comparative study of
ocular, oral, and dermal neoplasms</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>25</volume>: <fpage>105</fpage>&#x2013;<lpage>112</lpage>.
doi: <pub-id pub-id-type="doi">10.1177/030098588802500201</pub-id><pub-id pub-id-type="pmid">3363787</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Pulley</surname><given-names>L. T.</given-names></name><name><surname>Stannard</surname><given-names>A. A.</given-names></name></person-group><year>1990</year> Melanocytic tumor. pp. 75&#x2013;82. <italic>In</italic>:
Tumors in Domestic Animals, 3rd ed. (Moulton, J. E. ed.), University of California Press,
Berkeley.</mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Pumarola</surname><given-names>M.</given-names></name><name><surname>Anor</surname><given-names>S.</given-names></name><name><surname>Borras</surname><given-names>D.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name></person-group><year>1996</year>
<article-title>Malignant epithelioid schwannoma
affecting the trigeminal nerve of a dog</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>33</volume>: <fpage>434</fpage>&#x2013;<lpage>436</lpage>.
doi: <pub-id pub-id-type="doi">10.1177/030098589603300411</pub-id><pub-id pub-id-type="pmid">8817843</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sch&#xF6;niger</surname><given-names>S.</given-names></name><name><surname>Valentine</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>A.</given-names></name><name><surname>Summers</surname><given-names>B. A.</given-names></name></person-group><year>2011</year>
<article-title>Cutaneous schwannomas in 22
horses</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>48</volume>: <fpage>433</fpage>&#x2013;<lpage>442</lpage>.
doi: <pub-id pub-id-type="doi">10.1177/0300985810377072</pub-id><pub-id pub-id-type="pmid">20716761</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Schulman</surname><given-names>F. Y.</given-names></name><name><surname>Johnson</surname><given-names>O. T.</given-names></name><name><surname>Facemire</surname><given-names>P. R.</given-names></name><name><surname>Fanburg-Smith</surname><given-names>J. C.</given-names></name></person-group><year>2009</year>
<article-title>Feline peripheral nerve sheath tumor:
Histologic, immunohistochemical, and clinicopathologic correlation (59 tumors in 53
cats)</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>46</volume>: <fpage>1166</fpage>&#x2013;<lpage>1180</lpage>.
doi: <pub-id pub-id-type="doi">10.1354/vp.08-VP-0327-S-FL</pub-id><pub-id pub-id-type="pmid">19605904</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Tanimoto</surname><given-names>T.</given-names></name><name><surname>Ohtsuki</surname><given-names>Y.</given-names></name></person-group><year>1992</year>
<article-title>A solitary schwannoma in the cecum of a
cow</article-title>. <source><italic>Vet. Pathol.</italic></source><volume>29</volume>:
<fpage>81</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1177/030098589202900111</pub-id><pub-id pub-id-type="pmid">1557866</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>van der Linde-Sipman</surname><given-names>J. S.</given-names></name><name><surname>de Wit</surname><given-names>M. M.</given-names></name><name><surname>van Garderen</surname><given-names>E.</given-names></name><name><surname>Molenbeek</surname><given-names>R. F.</given-names></name><name><surname>van der Velde-Zimmermann</surname><given-names>D.</given-names></name><name><surname>de Weqer</surname><given-names>R. A.</given-names></name></person-group><year>1997</year>
<article-title>Cutaneous malignant melanomas in 57 cats:
identification of (amelanotic) signet-ring and balloon cell types and verification of
their origin by immunohistochemistry, electron microscopy, and in situ
hybridization</article-title>. <source><italic>Vet.
Pathol.</italic></source><volume>34</volume>: <fpage>31</fpage>&#x2013;<lpage>38</lpage>. doi:
<pub-id pub-id-type="doi">10.1177/030098589703400105</pub-id><pub-id pub-id-type="pmid">9150543</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Weiss</surname><given-names>S. W.</given-names></name><name><surname>Goldblum</surname><given-names>J. R.</given-names></name></person-group><year>2001</year> Epithelioid malignant peripheral nerve sheath tumor
(epithelioid malignant schwannoma). pp. 1235&#x2013;1240. <italic>In</italic>: Enzinger and
Weiss&#x2019;s Soft Tissue Tumors, 4th ed. (Weiss, S. W. and Goldblum, J. R. eds.), Mosby, St
Louis.</mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Weiss</surname><given-names>S. W.</given-names></name><name><surname>Goldblum</surname><given-names>J. R.</given-names></name></person-group><year>2001</year> Schwannoma (neurilemoma). pp. 1146&#x2013;1160.
<italic>In</italic>: Enzinger and Weiss&#x2019;s Soft Tissue Tumors, 4th ed. (Weiss, S. W. and
Goldblum, J. R. eds.), Mosby, St Louis.</mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Yang</surname><given-names>S. W.</given-names></name><name><surname>Yang</surname><given-names>K. M.</given-names></name><name><surname>Kang</surname><given-names>H. Y.</given-names></name><name><surname>Kim</surname><given-names>T. S.</given-names></name></person-group><year>2003</year>
<article-title>Intranuclear cytoplasmic pseudoinclusions
in pituitary adenomas</article-title>. <source><italic>Yonsei Med.
J.</italic></source><volume>44</volume>: <fpage>816</fpage>&#x2013;<lpage>820</lpage>
<pub-id pub-id-type="pmid">14584097</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Hirato</surname><given-names>J.</given-names></name><name><surname>Sasaki</surname><given-names>A.</given-names></name><name><surname>Yokoo</surname><given-names>H.</given-names></name><name><surname>Nakazato</surname><given-names>Y.</given-names></name><name><surname>Kurachi</surname><given-names>H.</given-names></name></person-group><year>1999</year>
<article-title>Intranuclear inclusions of meningioma
associated with abnormal cytoskeletal protein expression</article-title>.
<source><italic>Brain Tumor Pathol.</italic></source><volume>16</volume>:
<fpage>86</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1007/BF02478908</pub-id><pub-id pub-id-type="pmid">10746966</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
